Tonghua Guhong Pharmaceutical

Tonghua Guhong Pharmaceutical is a China-based pharmaceutical company specializing in the research, development, and manufacturing of treatments for cardiovascular and cerebrovascular diseases. The company is best known for its flagship product, Guhong Injection, which is widely used in China for treating conditions such as cerebral ischemia and stroke. Tonghua Guhong operates as a key subsidiary of the Buchang Pharma group, leveraging large-scale manufacturing capabilities and an extensive domestic distribution network. Its portfolio focuses on integrating traditional Chinese medicine principles with modern pharmaceutical technology to address chronic and acute vascular conditions.